HomeFGEN • NASDAQ
add
FibroGen Inc
Previous close
$1.20
Day range
$1.18 - $1.27
Year range
$0.33 - $19.47
Market cap
120.37M USD
Avg Volume
2.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 55.90M | 54.59% |
Operating expense | 22.82M | -33.42% |
Net income | -32.93M | 57.07% |
Net profit margin | -58.91 | 72.23% |
Earnings per share | -0.33 | 59.26% |
EBITDA | -30.24M | 58.64% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 177.60M | -50.11% |
Total assets | 365.87M | -32.06% |
Total liabilities | 552.02M | -2.72% |
Total equity | -186.16M | — |
Shares outstanding | 99.48M | — |
Price to book | -0.52 | — |
Return on assets | -19.67% | — |
Return on capital | 1,479.47% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -32.93M | 57.07% |
Cash from operations | -59.29M | 41.64% |
Cash from investing | 51.28M | -50.45% |
Cash from financing | -165.00K | -100.52% |
Net change in cash | -7.95M | -124.21% |
Free cash flow | -39.63M | 24.88% |
About
Founded
Jan 1, 1993
Headquarters
Website
Employees
486